Forced expression of miR-200c restores the chemotherapeutic sensitivity of breast cancer cells [15], while loss of miR-200 correlates with increased vimentin expression and decreased E-cadherin expression in breast cancer cells [11, 13, 14]. Here, VIM is linked to breast cancer.